Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization

The epidermal growth factor receptor (EGFR) is known to play a critical role in non-small cell lung cancer (NSCLC). Constitutively active EGFR mutations, including in-frame deletion in exon 19 and L858R point mutation in exon 21, contribute about 90% of all EGFR-activating mutations in NSCLC. Althou...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Yiu To, Yin, Shuying, Lu, Bingbing, Fan, Suyu, Yang, Ran, Bai, Ruihua, Zhang, Chengjuan, Bode, Ann M., Liu, Kangdong, Dong, Zigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835564/
https://www.ncbi.nlm.nih.gov/pubmed/29398601
http://dx.doi.org/10.1016/j.ebiom.2018.01.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835564/
https://www.ncbi.nlm.nih.gov/pubmed/29398601
http://dx.doi.org/10.1016/j.ebiom.2018.01.017

Ejemplares similares